Composition BPC-157: 10 mg Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Peptide identity and purity assessment via HPLC/LC-MS Assay development and calibration for quantitative analysis Chromatographic method optimization for impurity profiling Stability characterization of a lyophilized peptide under laboratory storage conditions Documentation Lot-specific COA available (HPLC/LC-MS) Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Manufactured in the USA in an ISO 9001based, cGMP-aligned facility Lot-specific COA (HPLC/LC-MS) with verification key Third-party verification link provided per lot (Janoshik) Lyophilized for transit stability
It has been approved for use in psoriatic arthritis (PsA) in the United States based on the Golimumab-Randomized Evaluation of Safety and Efficacy in Subjects With Psoriatic Arthritis Using a Human Anti-TNF Monoclonal Antibody (GO-REVEAL) trial
Microdosing refers to using doses lower than the FDA-approved starting amounts to achieve specific goals such as appetite control, metabolic stability or maintenance
GLP-1 therapy targets appetite and fat loss, while hormone optimization supports muscle preservation, metabolic balance, and long-term sustainability
Mller T, Apps MAJ
MDMA effects on MR-visible choline, glutamate, glutamine, and taurine were also determined
